September 11, 2021

Lyfebulb and Arena Pharmaceuticals Present: A Celebratory Conversation with the Winner of the 2021 Innovation Challenge in Inflammatory Bowel Disease

Tuesday, September 14 @ 4:00 PM EDT

We invite you to meet the 2021 Lyfebulb-Arena Pharmaceuticals Innovation Challenge Award winner, Atray Dixit, PhD, Co-founder and CEO at Coral Genomics, as part of Lyfebulb’s virtual Fireside Chat series. Join us for a dynamic conversation, lightly moderated by Lyfebulb CEO Karin Hehenberger, MD, PhD, with Atray and two members of our jury, Tina Aswani Omprakash, Lyfebulb Patient Ambassador, Founder at Own Your Crohn’s, and Co-founder at IBDesis, and Brad Vale, PhD, DVM, Founder and General Partner at Treo Ventures.

Topics will span the importance of entrepreneurship, how lived experience can, and should, spark innovation, and the impact of patient-driven innovation on the inflammatory bowel disease community as a whole. The discussion will also explore today’s research landscape in the field of IBD and promising innovations on the horizon.

Please register below if you are interested in learning about the impact of entrepreneurship and innovation on the IBD community and how individuals with a personal connection to the disease have been inspired to help others.